Correction to: HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection (Immunogenetics, (2016), 68, (401–416), 10.1007/s00251-016-0918-x);HLA class I molecular variation and peptide-binding properties suggest a model of joint divergent asymmetric selection

Immunogenetics

Volumn 68, Issue 6-7, 2016, Pages 401-416

  Buhler, Stéphane ^a,b   Nunes, José Manuel ^a   Sanchez Mazas, Alicia ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Asymmetric balancing selection; Functional variation; Heterozygous advantage; HLA class I polymorphism; Immune protection; Peptide binding properties

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; PEPTIDE FRAGMENT;

ARTICLE; GENE ACTIVITY; GENETIC POLYMORPHISM; GENETIC REGULATION; GENETIC SELECTION; GENETIC VARIATION; HUMAN; IMMUNOGENETICS; JOINT DIVERGENT ASYMMETRIC SELECTION; MOLECULAR EVOLUTION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN BINDING; GENE; GENETICS; HAPLOTYPE; METABOLISM; QUANTITATIVE TRAIT LOCUS;

EVOLUTION, MOLECULAR; GENES, MHC CLASS I; GENETIC VARIATION; GENETICS, POPULATION; HAPLOTYPES; HLA-C ANTIGENS; HUMANS; PEPTIDE FRAGMENTS; QUANTITATIVE TRAIT LOCI; RECEPTORS, KIR; SELECTION, GENETIC;

EID: 84970968885     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-017-1045-z     Document Type: Erratum

References (112)

1. Adams EJ, Parham P (2001) Species-specific evolution of MHC class I genes in the higher primates. Immunol Rev 183:41–64
2. Agresti A (2007) An introduction to categorical data analysis, 2nd edn. Wiley, New York
3. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A (2009) Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 127:26–39
4. Bitarello BD, Francisco RdS, Meyer D (2015) Heterogeneity of dN/dS ratios at the classical HLA class I genes over divergence time and across the allelic phylogeny. J Mol Evol 1–13
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–512
6. Black FL (1992) Why did they die? Science 258:1739–1740
7. Boyington JC, Sun PD (2002) A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol Immunol 38:1007–1021
8. Bronson PG, Mack SJ, Erlich HA, Slatkin M (2013) A sequence-based approach demonstrates that balancing selection in classical human leukocyte antigen (HLA) loci is asymmetric. Hum Mol Genet 22:252–261
9. Brusic V, Rudy G, Harrison LC (1998) MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res 26:368–371
10. Buhler S, Sanchez-Mazas A (2011) HLA DNA sequence variation among human populations: molecular signatures of demographic and selective events. PLoS ONE 6:e14643
11. Cadavid LF, Watkins DI (1997) Heirs of the jaguar and the anaconda: HLA, conquest and disease in the indigenous populations of the Americas. Tissue Antigens 50:209–218
12. Cavalli-Sforza LL, Bodmer WF (1971) The genetics of human populations. San Francisco
13. Chappell PE, Meziane EK, Harrison M, Magiera Ł, Hermann C, Mears L, Wrobel AG, Durant C, Nielsen LL, Buus S, Ternette N, Mwangi W, Butter C, Nair V, Ahyee T, Duggleby R, Madrigal A, Roversi P, Lea SM, Kaufman J (2015) Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding. eLife 4:e05345
14. Chelvanayagam G (1996) A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 45:15–26
15. Chu CC, Lin M, Nakajima F, Lee HL, Chang SL, Juji T, Tokunaga K (2001) Diversity of HLA among Taiwan’s indigenous tribes and the Ivatans in the Philippines. Tissue Antigens 58:9–18
16. Crow JF, Kimura M (1970) An introduction to population genetic theory. New York
17. Di D, Sanchez-Mazas A, Currat M (2015) Computer simulation of human leukocyte antigen genes supports two main routes of colonization by human populations in East Asia. BMC Evol Biol 15:1
18. Doherty PC, Zinkernagel R (1975) Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 256:50–52
19. Edinur HA, Dunn PPJ, Hammond L, Selwyn C, Brescia P, Askar M, Reville P, Velickovic ZM, Lea RA, Chambers GK (2013) HLA and MICA polymorphism in Polynesians and New Zealand Maori: implications for ancestry and health. Hum Immunol 74:1119–1129
20. Excoffier L, Lischer HEL (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10:564–567
21. Ferrara GB, Bacigalupo A, Lamparelli T, Lanino E, Delfino L, Morabito A, Parodi AM, Pera C, Pozzi S, Sormani MP, Bruzzi P, Bordo D, Bolognesi M, Bandini G, Bontadini A, Barbanti M, Frumento G (2001) Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 98:3150–3155
22. Forsberg L, Dannewitz J, Petersson E, Grahn M (2007) Influence of genetic dissimilarity in the reproductive success and mate choice of brown trout—females fishing for optimal MHC dissimilarity. J Evol Biol 20:1859–1869
23. Francisco RS, Buhler S, Nunes JM, Bitarello BD, França GS, Meyer D, Sanchez-Mazas A (2015) HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms. Immunogenetics 67:651–663
24. Froeschke G, Sommer S (2005) MHC class II DRB variability and parasite load in the striped mouse (Rhabdomys pumilio) in the Southern Kalahari. Mol Biol Evol 22:1254–1259
25. Fukami-Kobayashi K, Shiina T, Anzai T, Sano K, Yamazaki M, Inoko H, Tateno Y (2005) Genomic evolution of MHC class I region in primates. Proc Natl Acad Sci U S A 102:9230–9234
26. Garamszegi LZ (2014) Global distribution of malaria-resistant MHC-HLA alleles: the number and frequencies of alleles and malaria risk. Malar J 13:349
27. Garrigan D, Hedrick PW (2003) Perspective: detecting adaptive molecular polymorphism: lessons from the MHC. Evol Int J Org Evol 57:1707–1722
28. Hedrick PW (2002) Pathogen resistance and genetic variation at MHC loci. Evol Int J Org Evol 56:1902–1908
29. Hedrick PW, Whittam TS, Parham P (1991) Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and -B genes. Proc Natl Acad Sci U S A 88:5897–5901
30. Hill AVS (1998) The immunogenetics of human infectious diseases. Annu Rev Immunol 16:593–617
31. Hill AVS, Elvin J, Willis AC, Aidoo M, Allsopp CEM, Gotch FM, Ming Gao X, Takiguchis M, Greenwood BM, Townsend ARM, McMichael AJ, Whittle HC (1992) Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434–439
32. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M (2008) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61:1–13
33. Hothorn Torsten HK (2008) Implementing a class of permutation tests: the coin package. J Stat Softw
34. Huchard E, Knapp LA, Wang J, Raymond M, Cowlishaw G (2010) MHC, mate choice and heterozygote advantage in a wild social primate. Mol Ecol 19:2545–2561
35. Hughes AL, Nei M (1988) Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335:167–170
36. Ilmonen P, Penn DJ, Damjanovich K, Morrison L, Ghotbi L, Potts WK (2007) Major histocompatibility complex heterozygosity reduces fitness in experimentally infected mice. Genetics 176:2501–2508
37. Kangueane P, Sakharkar MK, Kolatkar PR, Ren EC (2001) Towards the MHC-Peptide combinatorics. Hum Immunol 62:539–556
38. Kimura M, Crow JF (1964) The number of alleles that can be maintained in a finite population. Genetics 49:725–738
39. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW (1996) Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 156:2068–2076
40. Lau Q, Yasukochi Y, Satta Y (2015) A limit to the divergent allele advantage model supported by variable pathogen recognition across HLA-DRB1 allele lineages. Tissue Antigens 86:343–352
41. Lenz TL (2011) Computational prediction of MHC II-antigen binding supports divergent allele advantage and explains trans-species polymorphism. Evol Int J Org Evol 65:2380–2390
42. Lenz TL, Eizaguirre C, Scharsack JP, Kalbe M, Milinski M (2009) Disentangling the role of MHC-dependent ‘good genes’ and ‘compatible genes’ in mate-choice decisions of three-spined sticklebacks Gasterosteus aculeatus under semi-natural conditions. J Fish Biol 75:2122–2142
43. Liao WWP, Arthur JW (2011a) Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function. PLoS ONE 6
44. Liao WWP, Arthur JW (2011a) Predicting peptide binding to major histocompatibility complex molecules. Autoimmun Rev 10:469–473
45. Lin M, Chu CC, Lee HL, Chang SL, Ohashi J, Tokunaga K, Akaza T, Juji T (2000) Heterogeneity of Taiwan’s indigenous population: possible relation to prehistoric Mongoloid dispersals. Tissue Antigens 55:1–9
46. Little AM, Parham P (1999) Polymorphism and evolution of class I and II genes and molecules. Rev Immunogenet 1:105–123
47. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, Nielsen M (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11. Nucleic Acids Res 36:W509–W512
48. Lundegaard C, Lund O, Buus S, Nielsen M (2010) Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 130:309–318
49. Mack SJ, Erlich H (2006) 13th International Histocompatibility Workshop Anthropology/Human Genetic Diversity Joint Report—Chapter 6: Population relationships as inferred from classical HLA genes. In: Hansen JA (ed) Immunobiology of the human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference. IHWG Press, Seattle, WA
50. Mainguy J, Worley K, Côté SD, Coltman DW (2006) Low MHC DRB class II diversity in the mountain goat: past bottlenecks and possible role of pathogens and parasites. Conserv Genet 8:885–891
51. Malécot G (1975) Heterozygosity and relationship in regularly subdivided populations. Theor Popul Biol 8:212–241
52. Martinsohn JT, Sousa AB, Guethlein LA, Howard JC (1999) The gene conversion hypothesis of MHC evolution: a review. Immunogenetics 50:168–200
53. McClelland EE, Penn DJ, Potts WK (2003) Major histocompatibility complex heterozygote superiority during coinfection. Infect Immun 71:2079–2086
54. McCutcheon JA, Gumperz J, Smith KD, Lutz CT, Parham P (1995) Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J Exp Med 181:2085–2095
55. Meyer D, Thomson G (2001) How selection shapes variation of the human major histocompatibility complex: a review. Ann Hum Genet 65:1–26
56. Meyer D, Single RM, Mack SJ, Erlich HA, Thomson G (2006) Signatures of demographic history and natural selection in the human major histocompatibility complex loci. Genetics 173:2121–2142
57. Mousadik AE, Petit RJ (1996) High level of genetic differentiation for allelic richness among populations of the argan tree [Argania spinosa (L.) Skeels] endemic to Morocco. Theor Appl Genet 92:832–839
58. Nei M, Hughes AL (1992) Balanced polymorphism and evolution by the birth-and-death process in the MHC loci. In: Tsuji K, Aizawa M, Sasazuki T (eds) 11th Histocompatibility Workshop and Conference. Oxford Univ. Press, Oxford, UK
59. Nei M, Rooney AP (2005) Concerted and birth-and-death evolution of multigene families. Annu Rev Genet 39:121–152
60. Neisig A, Melief CJM, Neefjes J (1998) Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol 160:171–179
61. Norman PJ, Hollenbach JA, Nemat-Gorgani N, Guethlein LA, Hilton HG, Pando MJ, Koram KA, Riley EM, Abi-Rached L, Parham P (2013) Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of Sub-Saharan Africans. PLoS Genet 9:e1003938
62. Nowak MA, Tarczy-Hornoch K, Austyn JM (1992) The optimal number of major histocompatibility complex molecules in an individual. Proc Natl Acad Sci U S A 89:10896–10899
63. Nunes JM, Riccio ME, Buhler S, Di D, Currat M, Ries F, Almada AJ, Benhamamouch S, Benitez O, Canossi A, Fadhlaoui-Zid K, Fischer G, Kervaire B, Loiseau P, De Oliveira DCM, Papasteriades C, Piancatelli D, Rahal M, Richard L, Romero M, Rousseau J, Spiroski M, Sulcebe G, Middleton D, Tiercy JM, Sanchez-Mazas A (2010) Analysis of the HLA population data (AHPD) submitted to the 15th International Histocompatibility/Immunogenetics Workshop by using the Gene[rate] computer tools accommodating ambiguous data (AHPD project report). Tissue Antigens 76:18–30
64. Nunes JM, Buhler S, Roessli D, Sanchez-Mazas A, HLA-net 2013 collaboration (2014) The HLA-net GENE[RATE] pipeline for effective HLA data analysis and its application to 145 population samples from Europe and neighbouring areas. Tissue Antigens 83:307–323
65. Parham P (2005) MHC class I molecules and kirs in human history, health and survival. Nat Rev Immunol 5:201–214
66. Parham P (2009) The immune system. Garland Science, London and New York
67. Parham P, Moffett A (2013) Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol 13:133–144
68. Parham P, Norman PJ, Abi-Rached L, Guethlein LA (2012) Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci 367:800–811
69. Penn DJ, Damjanovich K, Potts WK (2002) MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc Natl Acad Sci U S A 99:11260–11264
70. Peters B, Sidney J, Bourne P, Bui H-H, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, Nemazee D, Ponomarenko JV, Sathiamurthy M, Schoenberger SP, Stewart S, Surko P, Way S, Wilson S, Sette A (2005) The design and implementation of the immune epitope database and analysis resource. Immunogenetics 57:326–336
71. Pidala J, Wang T, Haagenson M, Spellman SR, Askar M, Battiwalla M, Baxter-Lowe LA, Bitan M, Fernandez-Viña M, Gandhi M, Jakubowski AA, Maiers M, Marino SR, Marsh SGE, Oudshoorn M, Palmer J, Prasad VK, Reddy V, Ringden O, Saber W, Santarone S, Schultz KR, Setterholm M, Trachtenberg E, Turner EV, Woolfrey AE, Lee SJ, Anasetti C (2013) Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. Blood 122:3651–3658
72. Potts WK, Slev PR (1995) Pathogen-based models favoring MHC genetic diversity. Immunol Rev 143:181–197
73. Prugnolle F, Manica A, Charpentier M, Guegan JF, Guernier V, Balloux F (2005) Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 15:1022–1027
74. Qutob N, Balloux F, Raj T, Liu H, Procé SM, Trowsdale J, Manica A (2011) Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics 64:165–175
75. R Core Team (2014) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
76. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213–219
77. Rao X, Hoof I, Costa AICAF, Baarle D, Keşmir C (2011) HLA class I allele promiscuity revisited. Immunogenetics 63:691–701
78. Rao X, De Boer RJ, van Baarle D, Maiers M, Kesmir C (2013) Complementarity of binding motifs is a general property of HLA-A and HLA-B molecules and does not seem to effect HLA haplotype composition. T Cell Biol 4:374
79. Rapin N, Hoof I, Lund O, Nielsen M (2001) The MHC motif viewer: a visualization tool for MHC binding motifs. Current protocols in immunology. Wiley
80. Reche PA, Reinherz EL (2003) Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 331:623–641
81. Riccio ME, Buhler S, Nunes JM, Vangenot C, Cuénod M, Currat M, Di D, Andreani M, Boldyreva M, Chambers G, Chernova M, Chiaroni J, Darke C, Di Cristofaro J, Dubois V, Dunn P, Edinur HA, Elamin N, Eliaou JF, Grubic Z, Jaatinen T, Kanga U, Kervaire B, Kolesar L, Kunachiwa W, Lokki ML, Mehra N, Nicoloso G, Paakkanen R, Voniatis DP, Papasteriades C, Poli F, Richard L, Romón Alonso I, Slavčev A, Sulcebe G, Suslova T, Testi M, Tiercy JM, Varnavidou A, Vidan-Jeras B, Wennerström A, Sanchez-Mazas A (2013) 16th IHIW: analysis of HLA population data, with updated results for 1996 to 2012 workshop data (AHPD project report). Int J Immunogenet 40:21–30
82. Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SGE (2015) The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res 43:D423–D431
83. Roomp K, Antes I, Lengauer T (2010) Predicting MHC class I epitopes in large datasets. BMC Bioinf 11:90
84. Sanchez-Mazas A, Fernandez-Viña M, Middleton D, Hollenbach JA, Buhler S, Di D, Rajalingam R, Dugoujon J-M, Mack SJ, Thorsby E (2011) Immunogenetics as a tool in anthropological studies. Immunology 133:143–164
85. Sanchez-Mazas A, Lemaître J-F, Currat M (2012) Distinct evolutionary strategies of human leucocyte antigen loci in pathogen-rich environments. Philos Trans R Soc LondB Biol Sci 367:830–839
86. Sanchez-Mazas A, Buhler S, Nunes JM (2013) A new HLA map of Europe: regional genetic variation and its implication for peopling history, disease-association studies and tissue transplantation. Hum Hered 76:162–177
87. Santos EJMd, McCabe A, Gonzalez-Galarza FF, Jones AR, Middleton D (2015) Allele frequencies net database: improvements for storage of individual genotypes and analysis of existing data. Hum Immunol
88. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 219:277–319
89. Shannon C (1948) A mathematical theory of communication. Bell Syst Tech J 27:379–423
90. Sidney J, Peters B, Frahm N, Brander C, Sette A (2008) HLA class I supertypes: a revised and updated classification. BMC Immunol 9:1
91. Slade RW, McCallum HI (1992) Overdominant vs. frequency-dependent selection at MHC loci. Genetics 132:861–864
92. Solberg OD, Mack SJ, Lancaster AK, Single RM, Tsai Y, Sanchez-Mazas A, Thomson G (2008) Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies. Hum Immunol 69:443–464
93. Sommer S (2005) The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool 2:16
94. Spurgin LG, Richardson DS (2010) How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc R Soc B Biol Sci 277:979–988
95. Takahata N, Nei M (1990) Allelic genealogy under overdominant and frequency-dependent selection and polymorphism of major histocompatibility complex loci. Genetics 124:967–978
96. Testi M, Battarra M, Lucarelli G, Isgro A, Morrone A, Akinyanju O, Wakama T, Nunes JM, Andreani M, Sanchez-Mazas A (2015) HLA-A-B-C-DRB1-DQB1 phased haplotypes in 124 Nigerian families indicate extreme HLA diversity and low linkage disequilibrium in Central-West Africa. Tissue Antigens n/a–n/a
97. The MHC sequencing consortium (1999) Complete sequence and gene map of a human major histocompatibility complex. Nature 401:921–923
98. Thomsen M, Lundegaard C, Buus S, Lund O, Nielsen M (2013) MHCcluster, a method for functional clustering of MHC molecules. Immunogenetics 65:655–665
99. Thursz MR, Thomas HC, Greenwood BM, Hill AVS (1997) Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 17:11–12
100. Trolle T, Metushi IG, Greenbaum JA, Kim Y, Sidney J, Lund O, Sette A, Peters B, Nielsen M (2015) Automated benchmarking of peptide-MHC class I binding predictions. Bioinformatics btv123
101. Trowsdale J (2011) The MHC, disease and selection. Immunol Lett 137:1–8
102. van Deutekom HWM, Keşmir C (2015) Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most? Immunogenetics 67:425–436
103. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B (2010) The immune epitope database 2.0. Nucleic Acids Res 38:D854–D862
104. Wakeland EK, Boehme S, She JX, Lu C-C, McIndoe RA, Cheng I, Ye Y, Potts WK (1990) Ancestral polymorphisms of MHC class II genes: divergent allele advantage. Immunol Res 9:115–122
105. Wickham H (2009) ggplot2. Springer, New York
106. Woelfing B, Traulsen A, Milinski M, Boehm T (2009) Does intra-individual major histocompatibility complex diversity keep a golden mean? Phil Trans R Soc B Biol Sci 364:117–128
107. Worley K, Collet J, Spurgin LG, Cornwallis C, Pizzari T, Richardson DS (2010) MHC heterozygosity and survival in red junglefowl. Mol Ecol 19:3064–3075
108. Wright S (1951) The genetical structure of populations. Ann Eugenics 15:323–354
109. Wroblewski EE, Norman PJ, Guethlein LA, Rudicell RS, Ramirez MA, Li Y, Hahn BH, Pusey AE, Parham P (2015) Signature patterns of MHC diversity in three gombe communities of wild chimpanzees reflect fitness in reproduction and immune defense against SIVcpz. PLoS Biol 13:e1002144
110. Yang Z, Wong WS, Nielsen R (2005) Bayes empirical Bayes inference of amino acid sites under positive selection. Mol Biol Evol 22:1107–1118
111. Zhang H, Lundegaard C, Nielsen M (2009) Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Bioinformatics 25:83–89
112. Zhang L, Udaka K, Mamitsuka H, Zhu S (2012) Toward more accurate pan-specific MHC-peptide binding prediction: a review of current methods and tools. Brief Bioinform 13:350–364